Jeremy Green, 10% Owner at ARRAY BIOPHARMA INC (ARRY), bought 75,000 shares at $3.60 ($270K) on 2016-01-12, disclosed to the SEC on 2016-01-14.
Open-market purchase of $270k ARRY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |